LifeMD is trading at $3.08, up 8.21%, amid broad-market sentiment; no company-specific catalyst explaining the October 2 pre-market move surfaced. - U.S. futures were higher ahead of the September jobs report, while healthcare-sector weakness pointed the other way. - LifeMD’s September 22 preferred-stock dividend announcement lists October 2 as its record date, but does not establish a reason for the common-stock gain.